Wikidata

(Q64363818)

English

A Study to Confirm the Efficacy and Safety of Different Dupilumab Dose Regimens in Adults With Atopic Dermatitis (AD)

clinical trial

In more languages

Statements

short name
SOLO-CONTINUE (English)
0 references
title
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Investigating the Efficacy and Safety of Multiple Dupilumab Dose Regimens Administered as Monotherapy for Maintaining Treatment Response in Patients With Atopic Dermatitis (English)
0 references
medical condition
dermatitis
0 references
eczema
0 references
start time
25 March 2015
0 references
end time
July 2016
0 references
number of participants
422
0 references
minimum age
18 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q64363818&oldid=1857691234"